Single dose of Sputnik V vaccine triggers strong antibody response: Study

 

A single dose of the Sputnik V vaccine may be enough to elicit strong antibody response against SARS-CoV-2, the virus that causes COVID-19, in already infected people, according to a study.

Previous studies have found that two doses of Sputnik V, a vector vaccine produced using a combination of two adenoviruses, results in 92 per cent efficacy against COVID-19 infection.


Adenoviruses are common viruses that cause a range of illness with cold-like symptoms such as fever and sore throat.

The new study, published on Tuesday in the journal Cell Reports Medicine, examined whether a single dose would achieve greater public health benefit than two doses by allowing protection of a larger population more quickly. Click Here

Comments

Popular posts from this blog

Facebook parent Meta's social VR platform Horizon hits 300,000 users

Understanding the impact of cookieless targeting in digital advertising

Garmin Fenix7 series, epix smartwatches launched in India: Details here